Protocol: Breast cancer application protocol: a randomised controlled trial to evaluate a self-management app for breast cancer survivorsinformation technologybreast tumoursquality in health careThe eHealth technologies that are being designed for chronic disease constitute a global trend towards health ...
Prognositic significance of P-cadherin expression in breast cancer: Protocol for a meta-analysis. Prognositic significance of P-cadherin expression in breast cancer: Protocol for a meta-analysis.breast cancer, meta-analysis, P-cadherin, prognosis, ... Y Xi,X Zhang,Z Yang,... - 《Other》 ...
Introduction: We believe that conservative treatment of early breast cancer may not require radiotherapy that encompasses the whole breast. We present here the clinico-pathological basis for this view, as well as a novel therapeutic approach that allows intra-operative radiotherapy to be safely and ac...
such as melanoma, lung cancer and colorectal cancer, scientists still focus on immune therapy and the immune microenvironment of BC, and the immune ecosystem within BC has been better elucidated recently with the advent of single-cell RNA-seq analysis...
Tumor-infiltrating T (TIL-T) cells have recently been characterized in several human cancer types by single-cell RNA sequencing (RNA-seq)23,24,25,26,27,28,29,30. However, a comprehensive atlas of tumor-infiltrating B (TIL-B) cells is still missing. B cells recognize antigens through B ...
Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging technique that scouts new cancer as it begins to metastasiz...
breast cancer. "The collaboration between doctors andindustrial designengineers has been key to define the different parameters that this first photographic protocol with clinical use establishes," says Belén Merck, head researcher of the project, specialist inbreast cancerand professor of the Degree in...
Dysregulated Notch signalling contributes to breast cancer development and progression, but validated tools to measure the level of Notch signalling in breast cancer subtypes and in response to systemic therapy are largely lacking. A transcriptomic signa
Although Ki-67 is a commonly used measure of cellular proliferation in breast cancer tissue, its utility as a biomarker for helping to guide therapy decisions has been clouded by technical and clinical questions. However, recent efforts to develop a framework for analyzing Ki-67 and data from ...
6,8 Methods Study Protocol The trial protocol is available in Supplement 1. This was a prospective clinical trial sponsored by the National Cancer Institute (NCI) that was coordinated by the Eastern Cooperative Oncology Group (ECOG) and subsequently ECOG-ACRIN Cancer Research Group and approved by...